Plasma concentrations and urinary excretion of the antiarrhythmic quaternary ammonium compound QX-572 in man
- 1 January 1975
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 8 (3-4) , 277-282
- https://doi.org/10.1007/bf00567128
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effects of the quaternary ammonium compound OX-572 on ventricular tachyarrhythmias complicating acute myocardial infarction.Heart, 1975
- Electrophysiological effects of the antiarrhythmic agent QX-572 in the human heart with special reference to rate-induced changes in effective refractory periodsCardiovascular Research, 1975
- Haemodynamic effects of the antiarrhythmic quaternary ammonium compound QX-572 in man.Heart, 1975
- Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.Heart, 1974
- Comparison of Methyllidocaine and Lidocaine on Arrhythmias Produced by Coronary Occlusion in the DogCirculation, 1973
- Enhancement of Intestinal Absorption of a Quaternary Ammonium Compound by Salicylate and TrichloroacetateJournal of Pharmaceutical Sciences, 1973
- Evaluation of Bretylium Tosylate for the Treatment of Premature Ventricular ContractionsCirculation, 1972
- Biliary Excretion of Quaternary Ammonium Compounds and Tertiary Amines in the RatActa Pharmacologica et Toxicologica, 1971
- Hepatic transport of mono and bisquaternary ammonium compoundsEuropean Journal of Pharmacology, 1970
- Comparative Distribution, Excretion, and Metabolism of 14C-Labeled Quaternary Ammonium Compounds of Promazine, Chlorpromazine, and TriflupromazineJournal of Pharmaceutical Sciences, 1970